Tuesday, October 1st, 2024

MUST Divests 400 Capitol for US$117 Million to Improve Leverage

Date of Report: September 30, 2024
Broker Name: CGS International Securities


Divestment of 400 Capitol for US$117 Million
MUST has announced the divestment of its property, 400 Capitol, for a total value of US$117 million. The transaction is expected to be completed in the fourth quarter of 2024. This sale represents a strategic move by MUST to streamline its portfolio and focus on improving its financial structure.


Use of Proceeds to Repay Debt
The net proceeds from the sale of 400 Capitol, along with existing cash reserves, will be utilized to repay US$130.7 million in loans that are due in 2025. This approach underscores MUST’s focus on reducing its debt burden and improving its financial position. The repayment of loans will also contribute to strengthening the company’s balance sheet ahead of upcoming financial obligations.


Improvement in Aggregate Leverage
Post-divestment, MUST’s proforma aggregate leverage is expected to improve to 54.2%, according to management. This improvement is a significant outcome of the sale and debt repayment plan, positioning MUST for better financial health and enhanced operational flexibility in the future.


This detailed overview, based on the September 30, 2024, report, outlines MUST’s divestment of 400 Capitol and its strategic focus on debt reduction and financial leverage improvement.

China State Construction International Holdings Ltd (3311 HK) : A long position with an entry at 11.62, targeting 12.50

China State Construction International Holdings Ltd (3311 HK) Current Price Movement: The stock has closed above its 52-week high and is trading above the 5-week EMA. This marks a continuation of a strong bullish...

Bullish Rebound Signals Strong Upside Potential for Sands China Ltd

Date of Report: September 23, 2024Broker: CGS International Securities Overview of Sands China Ltd. Sands China Ltd. (Stock Code: 1928) is a major player in the hospitality, retail, and entertainment sectors in Macau, China....

BeiGene Ltd (6160) Surges Amid Bullish Technicals: A Promising Investment Opportunity

Company HighlightsBeiGene Ltd (HKG: 6160) has recently emerged as a strong contender for investors looking for growth in the biopharmaceutical sector. As a commercial-stage company specializing in the discovery and commercialization of molecularly targeted...